Scholz Visit Paves Way For Limited China BioNTech Vaccine Use
Wider Approval To Follow?
Executive Summary
Recent visits by foreign dignitaries and progress with local mRNA vaccines and antivirals appear to be helping some slight relaxations in China's strict COVID policies, but some experts predict it may still take months for further steps.
You may also be interested in...
China Grants First mRNA COVID Vaccine Approval To Homegrown Latecomer
CSPC Pharmaceutical's SYS6006 has gained an emergency use authorization in China less than one year after entering clinical trials, becoming the first mRNA vaccine for COVID-19 to be approved in the country.
China Set To Green-Light First mRNA Vaccine
In what appears to be a step towards a gradual shift away from its strict "COVID Zero" policies, China is poised to approve its first mRNA vaccine - in this case developed domestically - and will accelerate the roll-out of COVID-19 vaccinations in general to seniors over 80.
China Eyes New COVID Vaccines As It Inches Towards Reopening
New planned changes around vaccine approvals and other COVID-19 measures signal China is preparing for a gradual reopening amid its strict policies, but the process could take months.